Lundbeck Foundation
Kevin joins from Boehringer Ingelheim where he as a Strategic Partner in Business Development has successfully been leading global licensing activities within Cardiometabolism and Retinal Health. Prior to that, Kevin worked at Novo Nordisk for several years in various positions within R&D, Global Marketing, and Business Development providing him a great insight and understanding of the whole value chain in the pharma industry.
Kevin holds an MSc in Biochemistry from the University of Copenhagen, and a Ph.D. from Max Planck Institute. Kevin has several high-impact publications including a first-author publication in ‘Cell’.
This person is not in any teams
Lundbeck Foundation
The Lundbeck Foundation is an active industrial Foundation. They fund biomedical sciences research – and they have a special fondness for the brain. They invest responsibly, sustainably and with a long-term perspective, focusing in particular on healthcare enterprises. All of their activities focus on improving lives and steering society in a healthier direction. Their ambition is for Denmark to become a leading research nation, with a flourishing business sector in the field of healthcare and offering exemplary diagnosis and treatment of patients with brain disorders.